{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:48:20Z","timestamp":1792460900316,"version":"4.5.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Orlistat, a potent inhibitor of gastric and pancreatic lipases, has been a cornerstone of pharmacological obesity management for over 2 decades. By reducing dietary fat absorption, it facilitates modest but clinically significant weight loss and helps prevent weight regain when combined with lifestyle interventions. Its use is associated with improvements in a range of obesity-related comorbidities, including enhanced glycemic control, reduced risk of type 2 diabetes progression, and favorable modifications of cardiovascular risk factors such as dyslipidemia. However, its clinical utility is often limited by predictable gastrointestinal adverse effects, which can impact patient adherence. Beyond its established role in weight control, a growing body of preclinical evidence has unveiled Orlistat\u2019s off-target activity as an inhibitor of fatty acid synthase (FASN), a key enzyme in\n                    <jats:italic>de novo<\/jats:italic>\n                    lipogenesis that is frequently overexpressed in various cancers. This discovery has spurred investigation into its potential as an anti-neoplastic agent, with studies demonstrating its ability to induce apoptosis, arrest cell cycle progression, and synergize with immunotherapy in cancer models. This review provides a comprehensive analysis of Orlistat, covering its molecular mechanisms, clinical efficacy and safety in diverse populations, impact on metabolic health, and the exciting, yet nascent, evidence for its repurposing in oncology.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1944242","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:09:46Z","timestamp":1789466986000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Orlistat: a comprehensive review of a lipase inhibitor from obesity management to emerging oncological applications"],"prefix":"10.3389","volume":"17","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[{"name":"Department of Clinical Nutrition, The Second Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchao","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.cgh.2007.07.009","article-title":"Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects","volume":"5","author":"Ahnen","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/obr.12318","article-title":"Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Aldekhail","year":"2015","journal-title":"Obes. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S2213-8587(24)00098-6","article-title":"Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review","volume":"12","author":"Alsaqaaby","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study","volume":"374","author":"Astrup","year":"2009","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jconrel.2024.08.021","article-title":"Prolonged release from lipid nanoemulsions by modification of drug lipophilicity","volume":"374","author":"Baumann","year":"2024","journal-title":"J. Control Release"},{"key":"B6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ijbiomac.2017.01.150","article-title":"Molecular recognition between pancreatic lipase and natural and synthetic inhibitors","volume":"98","author":"Bello","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.2337\/diacare.26.6.1667","article-title":"Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes","volume":"26","author":"Bergholm","year":"2003","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/gut.46.6.774","article-title":"Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor","volume":"46","author":"Borovicka","year":"2000","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.cmet.2018.07.019","article-title":"Impairment of angiogenesis by fatty acid synthase inhibition involves mTOR malonylation","volume":"28","author":"Bruning","year":"2018","journal-title":"Cell Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/gutjnl-2023-330826","article-title":"High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT","volume":"73","author":"Bu","year":"2024","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","first-page":"144876","DOI":"10.1016\/j.foodchem.2025.144876","article-title":"Synthesis, characterization, and in vitro hypolipidemic mechanisms of sugar-SA triazole conjugates as potent pancreatic lipase inhibitors","volume":"488","author":"Cao","year":"2025","journal-title":"Food Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1001\/jama.293.23.2873","article-title":"Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial","volume":"293","author":"Chanoine","year":"2005","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2407942","DOI":"10.1002\/advs.202407942","article-title":"HACD2 promotes pancreatic cancer progression by enhancing PKM2 dissociation from PRKN in a dehydratase-independent manner","volume":"12","author":"Chu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"100105","DOI":"10.1016\/j.pharmr.2025.100105","article-title":"Targeting fatty acid synthase for cancer drug discovery: retrospective analyses and outlook","volume":"78","author":"Cui","year":"2026","journal-title":"Pharmacol. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1467-789X.2009.00620.x","article-title":"Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials","volume":"11","author":"Czernichow","year":"2010","journal-title":"Obes. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1177\/1741826711406058","article-title":"Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study","volume":"19","author":"Czernichow","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2337\/diacare.27.5.1077","article-title":"Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients","volume":"27","author":"Damci","year":"2004","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.281.3.235","article-title":"Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial","volume":"281","author":"Davidson","year":"1999","journal-title":"JAMA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"g2646","DOI":"10.1136\/bmj.g2646","article-title":"Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials","volume":"348","author":"Dombrowski","year":"2014","journal-title":"BMJ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"f1936","DOI":"10.1136\/bmj.f1936","article-title":"Orlistat and the risk of acute liver injury: self controlled case series study in UK clinical practice research datalink","volume":"346","author":"Douglas","year":"2013","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1053\/ajkd.2003.50061","article-title":"Drug interaction in a renal transplant patient: cyclosporin-neoral and orlistat","volume":"41","author":"Evans","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1467-789X.2009.00567.x","article-title":"Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis","volume":"10","author":"Fabricatore","year":"2009","journal-title":"Obes. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1021\/cs500956m","article-title":"Mechanism of orlistat hydrolysis by the thioesterase of human fatty acid synthase","volume":"4","author":"Fako","year":"2014","journal-title":"ACS Catal."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1053\/gast.2001.23232","article-title":"Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans","volume":"120","author":"Feinle","year":"2001","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1523-1755.2004.00790.x","article-title":"Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion","volume":"66","author":"Ferraz","year":"2004","journal-title":"Kidney Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.canlet.2005.09.011","article-title":"The anti-obesity agent orlistat is associated to increase in colonic preneoplastic markers in rats treated with a chemical carcinogen","volume":"240","author":"Garcia","year":"2006","journal-title":"Cancer Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","article-title":"Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis","volume":"334","author":"Gillies","year":"2007","journal-title":"BMJ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e13704","DOI":"10.1111\/obr.13704","article-title":"Anti-obesity pharmacological agents for polycystic ovary syndrome: a systematic review and meta-analysis to inform the 2023 international evidence-based guideline","volume":"25","author":"Goldberg","year":"2024","journal-title":"Obes. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.biopsych.2005.03.001","article-title":"Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Grilo","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hep.20589","article-title":"Effective oral treatment of unconjugated hyperbilirubinemia in Gunn rats","volume":"41","author":"Hafkamp","year":"2005","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1572-0241.2003.07375.x","article-title":"Orlistat in the treatment of NASH: a case series","volume":"98","author":"Harrison","year":"2003","journal-title":"Am. J. Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.2337\/diacare.21.8.1288","article-title":"Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study","volume":"21","author":"Hollander","year":"1998","journal-title":"Diabetes Care"},{"key":"B35","doi-asserted-by":"publisher","first-page":"f5039","DOI":"10.1136\/bmj.f5039","article-title":"Risk of colorectal cancer after initiation of orlistat: matched cohort study","volume":"347","author":"Hong","year":"2013","journal-title":"BMJ"},{"key":"B36","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1158\/0008-5472.CAN-23-0966","article-title":"FASN inhibition decreases MHC-I degradation and synergizes with PD-L1 checkpoint blockade in hepatocellular carcinoma","volume":"84","author":"Huang","year":"2024","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e3002960","DOI":"10.1371\/journal.pbio.3002960","article-title":"Maternal lipid mobilization is essential for embryonic development in the malaria vector Anopheles gambiae","volume":"22","author":"Itoe","year":"2024","journal-title":"PLoS Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1467-789X.2009.00581.x","article-title":"Discontinuation due to adverse events in randomized trials of orlistat, sibutramine and rimonabant: a meta-analysis","volume":"10","author":"Johansson","year":"2009","journal-title":"Obes. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2337\/diacare.25.6.1033","article-title":"Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: a 1-year randomized controlled trial","volume":"25","author":"Kelley","year":"2002","journal-title":"Diabetes Care"},{"key":"B40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2337\/diacare.27.1.33","article-title":"Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes","volume":"27","author":"Kelley","year":"2004","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1001\/jama.2016.7602","article-title":"Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis","volume":"315","author":"Khera","year":"2016","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1053\/j.gastro.2017.12.024","article-title":"Effects of weight-loss medications on cardiometabolic risk profiles: a systematic review and network meta-analysis","volume":"154","author":"Khera","year":"2018","journal-title":"Gastroenterology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/0016-5085(92)91452-a","article-title":"Comparison of different treatment modalities in experimental pancreatitis in rats","volume":"103","author":"Kimura","year":"1992","journal-title":"Gastroenterology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1038\/s41598-020-62427-8","article-title":"Crystal structure of pathogenic Staphylococcus aureus lipase complex with the anti-obesity drug orlistat","volume":"10","author":"Kitadokoro","year":"2020","journal-title":"Sci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1158\/0008-5472.can-03-3645","article-title":"Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity","volume":"64","author":"Kridel","year":"2004","journal-title":"Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2337\/diacare.25.2.303","article-title":"A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients","volume":"25","author":"Lamotte","year":"2002","journal-title":"Diabetes Care"},{"key":"B47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7326\/0003-4819-155-7-201110040-00006","article-title":"Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. preventive services task force","volume":"155","author":"Leblanc","year":"2011","journal-title":"Ann. Intern Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","article-title":"Meta-analysis: pharmacologic treatment of obesity","volume":"142","author":"Li","year":"2005","journal-title":"Ann. Intern Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"147031","DOI":"10.1016\/j.foodchem.2025.147031","article-title":"Bioactivity-guided isolation of pancreatic lipase inhibitors from Lycium ruthenicum using a novel HPLC-FLD\/pancreatic lipase online recognition system","volume":"497","author":"Li","year":"2025","journal-title":"Food Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e02154","DOI":"10.1002\/advs.202502154","article-title":"ORL@Cu-MOF boost cuproptosis and suppress fatty acid metabolism for cancer lymph node metastasis synergistic therapy","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1365-2796.2000.00720.x","article-title":"The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish multimorbidity study","volume":"248","author":"Lindgarde","year":"2000","journal-title":"J. Intern Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1158\/0008-5472.CAN-06-1794","article-title":"Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells","volume":"67","author":"Little","year":"2007","journal-title":"Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1053\/j.ajkd.2009.09.011","article-title":"Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up","volume":"55","author":"MacLaughlin","year":"2010","journal-title":"Am. J. Kidney Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.metabol.2009.02.031","article-title":"Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects","volume":"58","author":"Madsen","year":"2009","journal-title":"Metabolism"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/obr.12707","article-title":"Effects of intentional weight loss in patients with obesity and heart failure: a systematic review","volume":"19","author":"McDowell","year":"2018","journal-title":"Obes. Rev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1038\/s41591-025-03978-z","article-title":"A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults","volume":"31","author":"McGowan","year":"2025","journal-title":"Nat. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/annonc\/mdi239","article-title":"Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2\/neu (erbB-2) oncogene","volume":"16","author":"Menendez","year":"2005","journal-title":"Ann. Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2337\/diacare.25.7.1123","article-title":"Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin","volume":"25","author":"Miles","year":"2002","journal-title":"Diabetes Care"},{"key":"B59","doi-asserted-by":"publisher","first-page":"10814","DOI":"10.1021\/ja505639u","article-title":"Total synthesis of tetrahydrolipstatin and stereoisomers via a highly regio- and diastereoselective carbonylation of epoxyhomoallylic alcohols","volume":"136","author":"Mulzer","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"B60","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/gutjnl-2014-308043","article-title":"Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections","volume":"65","author":"Noel","year":"2016","journal-title":"Gut"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1001\/jama.2017.0332","article-title":"Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US preventive services task force","volume":"317","author":"O'Connor","year":"2017","journal-title":"JAMA"},{"key":"B62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jama.2024.6739","article-title":"Interventions for weight management in children and adolescents: updated evidence report and systematic review for the US preventive services task force","volume":"332","author":"O'Connor","year":"2024","journal-title":"JAMA"},{"key":"B63","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2337\/diacare.28.3.736","article-title":"A systematic review of drug therapy to delay or prevent type 2 diabetes","volume":"28","author":"Padwal","year":"2005","journal-title":"Diabetes Care"},{"key":"B64","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/sj.leu.2405058","article-title":"Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells","volume":"22","author":"Pallasch","year":"2008","journal-title":"Leukemia"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e02060","DOI":"10.1002\/adhm.202502060","article-title":"Synergistic combination of tamoxifen-tetraphenylethylene Co-Assembled micelles and Orlistat-Induced lipid droplet inhibition to overcome tamoxifen resistance","volume":"14","author":"Park","year":"2025","journal-title":"Adv. Healthc. Mater"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/ejhf.3270","article-title":"Intentional weight loss in overweight and obese patients with heart failure: a systematic review","volume":"26","author":"Peck","year":"2024","journal-title":"Eur. J. Heart Fail"},{"key":"B67","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nsmb1265","article-title":"Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by orlistat","volume":"14","author":"Pemble","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"CD003619","DOI":"10.1002\/14651858.CD003619.pub3","article-title":"Weight reduction for non-alcoholic fatty liver disease","volume":"6","author":"Peng","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0026-0495(94)90095-7","article-title":"Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor","volume":"43","author":"Reitsma","year":"1994","journal-title":"Metabolism"},{"key":"B70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2337\/dc06-0210","article-title":"Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study","volume":"30","author":"Richelsen","year":"2007","journal-title":"Diabetes Care"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/bmj.39385.413113.25","article-title":"Long term pharmacotherapy for obesity and overweight: updated meta-analysis","volume":"335","author":"Rucker","year":"2007","journal-title":"BMJ"},{"key":"B72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.phrs.2017.05.022","article-title":"Effect of orlistat on plasma lipids and body weight: a systematic review and meta-analysis of 33 randomized controlled trials","volume":"122","author":"Sahebkar","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1172\/JCI38942","article-title":"Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction","volume":"120","author":"Samudio","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e1002101","DOI":"10.1371\/journal.pmed.1002101","article-title":"Assessment of adverse events in protocols, clinical study reports, and published papers of trials of orlistat: a document analysis","volume":"13","author":"Schroll","year":"2016","journal-title":"PLoS Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(24)00351-9","article-title":"Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials","volume":"403","author":"Shi","year":"2024","journal-title":"Lancet"},{"key":"B76","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/j.ajkd.2006.10.004","article-title":"Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor","volume":"49","author":"Singh","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"B77","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European multicentre orlistat study group","volume":"352","author":"Sjostrom","year":"1998","journal-title":"Lancet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"11199","DOI":"10.1038\/ncomms11199","article-title":"FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth","volume":"7","author":"Slebe","year":"2016","journal-title":"Nat. Commun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cmet.2014.05.022","article-title":"Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal","volume":"20","author":"Sounni","year":"2014","journal-title":"Cell Metab."},{"key":"B80","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1158\/0008-5472.CAN-16-3062","article-title":"De novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer","volume":"77","author":"Tadros","year":"2017","journal-title":"Cancer Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e008923","DOI":"10.1136\/jitc-2024-008923","article-title":"Orlistat facilitates immunotherapy via AKT-FOXO3a-FOXM1-mediated PD-L1 suppression","volume":"13","author":"Tang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/obr.12720","article-title":"Pharmacologic therapy to induce weight loss in women who have obesity\/overweight with polycystic ovary syndrome: a systematic review and network meta-analysis","volume":"19","author":"Wang","year":"2018","journal-title":"Obes. Rev."},{"key":"B84","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-023-01405-8","article-title":"FBXW7beta loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth","volume":"8","author":"Wei","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/art.42996","article-title":"Weight loss after receiving anti-obesity medications and gout among individuals with overweight and Obese: a population-based cohort study","volume":"77","author":"Wei","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.7150\/ijbs.104485","article-title":"NAMPT impairs vascular permeability in periodontitis by influencing FASN-mediated lipogenesis","volume":"21","author":"Xiao","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1021\/ja907716f","article-title":"Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities","volume":"132","author":"Yang","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"B88","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1001\/jama.2013.281361","article-title":"Long-term drug treatment for obesity: a systematic and clinical review","volume":"311","author":"Yanovski","year":"2014","journal-title":"JAMA"},{"key":"B89","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41419-025-07661-6","article-title":"Targeting oncogenic activation of FLT3\/SREBP\/FASN promotes the therapeutic effect of quizartinib involving disruption of mitochondrial phospholipids","volume":"16","author":"Yin","year":"2025","journal-title":"Cell Death Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.cgh.2006.02.004","article-title":"A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease","volume":"4","author":"Zelber-Sagi","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.cmet.2014.04.003","article-title":"alpha\/beta-hydrolase domain-6-accessible monoacylglycerol controls glucose-stimulated insulin secretion","volume":"19","author":"Zhao","year":"2014","journal-title":"Cell Metab."},{"key":"B92","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40168-025-02133-7","article-title":"Lipid accumulation inhibition strategies alleviate fusobacterium nucleatum-infected colorectal cancer","volume":"13","author":"Zhou","year":"2025","journal-title":"Microbiome"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1944242\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:09:47Z","timestamp":1789466987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1944242\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":92,"alternative-id":["10.3389\/fphar.2026.1944242"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1944242","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1944242"}}